WallStreetZenWallStreetZen

NYSEMKT: SER
Serina Therapeutics Inc Stock Ownership - Who owns Serina Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Serina Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jay VenkatesanDirector2026-03-317,553$1.94
$14.65kBuy
Gregory BaileyDirector2026-03-3159,667$1.94
$115.75kBuy
Randall MoreadithChief Scientific Officer2026-03-236,500$2.86
$18.57kSell
Randall MoreadithChief Scientific Officer2026-03-236,500$0.06
$390.00Buy
Randall MoreadithChief Scientific Officer2026-03-1939,000$2.50
$97.50kSell
Randall MoreadithChief Scientific Officer2026-03-1939,000$0.06
$2.34kBuy
Randall MoreadithChief Scientific Officer2026-02-026,500$3.03
$19.68kSell
Randall MoreadithChief Scientific Officer2026-02-026,500$0.06
$390.00Buy
Randall MoreadithChief Scientific Officer2026-01-286,500$3.57
$23.19kSell
Randall MoreadithChief Scientific Officer2026-01-286,500$0.06
$390.00Buy

1 of 9

SER insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SER insiders and whales buy or sell their stock.

SER Shareholders

What type of owners hold Serina Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Juvenescence Ltd182.57%22,481,876$40.47MInsider
Juvenescence Us Corp133.57%16,447,500$29.61MInsider
Steven A. Ledger2.63%323,657$582.58kInsider
Vanguard Group Inc1.46%180,013$324.02kInstitution
Gregory Bailey1.03%126,910$228.44kInsider
John F. Mauldin1.02%125,000$225.00kInsider
Waverly Advisors LLC0.55%67,492$121.49kInstitution
Tacey Viegas0.48%58,610$105.50kInsider
Broadwood Capital Inc0.44%54,484$98.07kInstitution
Judith Segall0.43%52,624$94.72kInsider

1 of 3

SER vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SER1.07%98.93%Net BuyingNet Buying
VYNE24.04%75.96%Net SellingNet Selling
AEON5.24%94.76%Net Buying
PLRZ0.94%5.29%Net SellingNet Selling
ALLR8.17%14.25%Net Selling
View Top Biotech Stocks

Serina Therapeutics Stock Ownership FAQ

Who owns Serina Therapeutics?

Serina Therapeutics (NYSEMKT: SER) is owned by 3.49% institutional shareholders, 322.71% Serina Therapeutics insiders, and 0.00% retail investors. Juvenescence Ltd is the largest individual Serina Therapeutics shareholder, owning 22.48M shares representing 182.57% of the company. Juvenescence Ltd's Serina Therapeutics shares are currently valued at $41.14M.

If you're new to stock investing, here's how to buy Serina Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.